Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Market Cap	52.97B
Revenue (ttm)	19.98B
Net Income (ttm)	2.49B
Shares Out	1.59B
EPS (ttm)	1.57
PE Ratio	21.23
Forward PE	14.54
Dividend	1.01 (3.02%)
Ex-Dividend Date	Oct 23, 2024

Volume	14,761,100
Average Volume	17,693,418
Open	34.05
Previous Close	33.30
Day's Range	33.50 - 34.19
52-Week Range	25.72 - 38.08
Beta	-0.02
RSI	48.04
Earnings Date	Apr 24, 2025

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sic...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 21,864
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2024, SHE:002422's revenue was 21.81 billion, an increase of 1.67% compared to the previous year's 21.45 billion. Earnings were 2.94 billion, an increase of 19.53%.